Sean G. Buchanan

5.0k citations

47 papers · 1.8k indexed · h-index 20

Molecular Biology top 10%
Oncology top 5%
Pulmonary and Respiratory Medicine top 10%
Genetics top 5%
Pathology and Forensic Medicine top 10%

Co-authors: Nicholas J. Gay Sheng-Bin Peng Vipin Yadav Xueqian Gong James J. Starling Richard P. Beckmann Youyan Zhang James R. Henry
Topics: Advanced Breast Cancer Therapies (15 papers)Cancer-related Molecular Pathways (12 papers)Chronic Lymphocytic Leukemia Research (7 papers)
Cited by: Oncology Genetics Molecular Biology
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Journal of Clinical Oncology
Partner nations: United States United Kingdom Spain

In The Last Decade

Sean G. Buchanan

46 papers receiving 1.7k citations

Peers

Countries citing papers authored by Sean G. Buchanan

Since Specialization

Citations

This map shows the geographic impact of Sean G. Buchanan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sean G. Buchanan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sean G. Buchanan more than expected).

Fields of papers citing papers by Sean G. Buchanan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sean G. Buchanan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sean G. Buchanan. The network helps show where Sean G. Buchanan may publish in the future.

Co-authorship network of co-authors of Sean G. Buchanan

This figure shows the co-authorship network connecting the top 25 collaborators of Sean G. Buchanan. A scholar is included among the top collaborators of Sean G. Buchanan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sean G. Buchanan. Sean G. Buchanan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of a Cloud-Based Clinical Decision Support System for Ophthalmology Triage Using Decision Tree Artificial Intelligence 2022 ·SHILAP Revista de lepidopterología ·(unknown),Anne Xuan-Lan Nguyen,Sean G. Buchanan,(unknown)	14
2	Distinct CDK6 complexes determine tumor cell response to CDK4/6 inhibitors and degraders 2021 ·Nature Cancer ·Xuewei Wu,Xiaobao Yang,Yan Xiong,Ruitong Li,Takahiro Ito,Tamer A. Ahmed,Zoi Karoulia,Christos Adamopoulos,Hong Wang,Li Wang,Ling Xie,Jing Liu,Beatrix Ueberheide,Stuart A. Aaronson,Xian Chen,Sean G. Buchanan,William R. Sellers,Jian Jin,Poulikos I. Poulikakos	47
3	Abemaciclib Is Active in Preclinical Models of Ewing Sarcoma via Multipronged Regulation of Cell Cycle, DNA Methylation, and Interferon Pathway Signaling 2018 ·Clinical Cancer Research ·Michele Dowless,Caitlin D. Lowery,Terry J. Shackleford,(unknown),Jennifer Stephens,(unknown),Wayne Blosser,Simone Gupta,Julie Stewart,Yue Webster,Jack Dempsey,(unknown),Philip J. Ebert,Philip W. Iversen,Jonathan B. Olsen,Xueqian Gong,Sean G. Buchanan,Peter J. Houghton,Louis F. Stancato	47
4	RAF inhibitor LY3009120 sensitizes RAS or BRAF mutant cancer to CDK4/6 inhibition by abemaciclib via superior inhibition of phospho-RB and suppression of cyclin D1 2017 ·Oncogene ·S-H Chen,(unknown),(unknown),Robert D. Van Horn,Taiqi Yin,L. Julie Huber,T. Burke,Jason R. Manro,Philip W. Iversen,Wenjuan Wu,Shripad V. Bhagwat,Richard P. Beckmann,Ramón V. Tiu,Sean G. Buchanan,(unknown)	58
5	Oncogenic BRAF Deletions That Function as Homodimers and Are Sensitive to Inhibition by RAF Dimer Inhibitor LY3009120 2016 ·Cancer Discovery ·Shih-Hsun Chen,Youyan Zhang,Robert D. Van Horn,Tinggui Yin,Sean G. Buchanan,Vipin Yadav,Igor Mochalkin,Swee Seong Wong,Yong Yue,Lysiane Huber,Ilaria Conti,James R. Henry,James J. Starling,Gregory D. Plowman,Sheng-Bin Peng	117
6	The CDK4/6 Inhibitor LY2835219 Overcomes Vemurafenib Resistance Resulting from MAPK Reactivation and Cyclin D1 Upregulation 2014 ·Molecular Cancer Therapeutics ·Vipin Yadav,Teresa F. Burke,Lysiane Huber,Robert D. Van Horn,Youyan Zhang,Sean G. Buchanan,Edward M. Chan,James J. Starling,Richard P. Beckmann,Sheng-Bin Peng	104
7	Identification of Druggable Cancer Driver Genes Amplified across TCGA Datasets 2014 ·PLoS ONE ·Ying Chen,(unknown),Xian‐Ming Chen,Thompson N. Doman,Xueqian Gong,Youyan Zhang,(unknown),Xiwen Ma,Richard E. Higgs,Shripad V. Bhagwat,Sean G. Buchanan,Sheng-Bin Peng,Kirk A. Staschke,Vipin Yadav,Yong Yue,Hosein Kouros‐Mehr	108
8	Evolving toward a human-cell based and multiscale approach to drug discovery for CNS disorders 2014 ·Frontiers in Pharmacology ·Eric E. Schadt,Sean G. Buchanan,Kristen Brennand,Kalpana Merchant	31
9	MET Kinase Inhibitor SGX523 Synergizes with Epidermal Growth Factor Receptor Inhibitor Erlotinib in a Hepatocyte Growth Factor–Dependent Fashion to Suppress Carcinoma Growth 2010 ·Cancer Research ·Yuwen Zhang,Ben Staal,Curt J. Essenburg,Yanli Su,Liang Kang,Richard West,Dafna Kaufman,(unknown),Bryn Eagleson,Sean G. Buchanan,George F. Vande Woude	61
10	In vitro and in vivo antitumor activities of SGX523, a novel MET inhibitor 2007 ·Molecular Cancer Therapeutics ·Katayoun A. Jessen,Karen Froning,(unknown),Andres Gutierrez,Marshall C. Peterman,(unknown),(unknown),Nanni Huser,(unknown),(unknown),(unknown),(unknown),S.K. Burley,Siegfried Reich,Sean G. Buchanan	3
11	Selective inhibition of MET protein receptor tyrosine kinase by SGX523 2007 ·Molecular Cancer Therapeutics ·(unknown),Brandon E. Aubol,(unknown),J. Hendle,Patrick Lee,Katayoun A. Jessen,Karen Froning,(unknown),J.M. Sauder,Kenneth D. Schwinn,Jeff Blaney,S.K. Burley,Siegfried Reich,Sean G. Buchanan	6
12	The 1.59 Å resolution crystal structure of TM0096, a flavin mononucleotide binding protein from Thermotoga maritima 2004 ·Proteins Structure Function and Bioinformatics ·(unknown),K.S. Gajiwala,B.W. Noland,(unknown),(unknown),(unknown),(unknown),Barbra Pagarigan,(unknown),Jon A. Christopher,Thomas S. Peat,John Badger,J. Hendle,(unknown),Sean G. Buchanan	17
13	A Novel Mode of Gleevec Binding Is Revealed by the Structure of Spleen Tyrosine Kinase 2004 ·Journal of Biological Chemistry ·S. Atwell,J.M. Adams,John Badger,(unknown),I. Feil,Karen Froning,Xia Gao,J. Hendle,Kevin Keegan,(unknown),(unknown),V. Nienaber,B.W. Noland,Kai Post,Kanagalaghatta R. Rajashankar,Aurora Ramos,Marijane Russell,S.K. Burley,Sean G. Buchanan	161
14	Structural Studies of Salmonella typhimurium ArnB (PmrH) Aminotransferase 2002 ·Structure ·B.W. Noland,Janet Newman,J. Hendle,John Badger,Jon A. Christopher,(unknown),(unknown),(unknown),M. Rutter,Wendy E. Sanderson,(unknown),K.S. Gajiwala,Sean G. Buchanan	63
15	The Promise of Structural Genomics in the Discovery of New Antimicrobial Agents 2002 ·Current Pharmaceutical Design ·Sean G. Buchanan,J.M. Sauder,Tess Harris	9
16	A Structural Genomics Approach to the Study of Quorum Sensing 2001 ·Structure ·H.A. Lewis,(unknown),(unknown),(unknown),(unknown),J.M. Adams,(unknown),(unknown),Thomas S. Peat,Wendy E. Sanderson,J.M. Sauder,Sean G. Buchanan	80
17	Promoter sequence and expression of the leucine-rich repeat gene LRR47: evidence for cytoplasmic and nuclear localization in Drosophila embryos and cells 1998 ·Gene ·Sean G. Buchanan,(unknown),(unknown)	1
18	Structural and functional diversity in the leucine-rich repeat family of proteins 1996 ·Progress in Biophysics and Molecular Biology ·Sean G. Buchanan,Nicholas J. Gay	265
19	Sequence and expression of LRR47, a novel embryonic leucine rich repeat protein of Drosophila 1994 ·Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression ·Monde Ntwasa,Sean G. Buchanan,Nicholas J. Gay	7
20	Drosophila ribosomal protein L18a: cDNA sequence, expression and chromosomal localization of the gene 1994 ·Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression ·Monde Ntwasa,Sean G. Buchanan,Nicholas J. Gay	2

About Sean G. Buchanan

Sean G. Buchanan is a scholar working on Oncology, Genetics and Pulmonary and Respiratory Medicine, having authored 47 papers that have together received 1.8k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (15 papers), Cancer-related Molecular Pathways (12 papers) and Chronic Lymphocytic Leukemia Research (7 papers). The work is most often cited by research in Oncology (605 citations), Genetics (196 citations) and Molecular Biology (1.0k citations). Sean G. Buchanan has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Nicholas J. Gay, Sheng-Bin Peng, Vipin Yadav, Xueqian Gong, James J. Starling, Richard P. Beckmann, Youyan Zhang, James R. Henry, Robert D. Van Horn and Lysiane Huber. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact